Aredia and Temovate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aredia (pamidronate disodium) and Temovate (clobetasol propionate). Common drug interactions include emotional distress among females and gastrointestinal haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Aredia and Temovate. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Aredia?

Aredia has active ingredients of pamidronate disodium. It is often used in breast cancer. eHealthMe is studying from 15,364 Aredia users. Check the latest studies of Aredia.

What is Temovate?

Temovate has active ingredients of clobetasol propionate. eHealthMe is studying from 1,392 Temovate users. Check the latest studies of Temovate.

On Jul, 29, 2026

14 people who take Aredia and Temovate together, and have interactions are studied.

What are the common drug interactions of Aredia and Temovate, by gender? *:

female:

Emotional distress
Metastases to bone (cancer spreads to bone)
Metastases to liver (cancer spreads to liver)
Metastases to lung (cancer spreads to lung)
Osteonecrosis of jaw (death of bone of jaw)
Breast cancer recurrent
Hepatic steatosis (fatty liver disease)
Hepatitis c
Mass
Splenomegaly (enlargement of spleen)

male:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Abdominal pain
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Ascites (accumulation of fluid in the abdominal cavity)
Back pain
Blood glucose decreased
Bone pain
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiomegaly (increased size of heart than normal)

What are the common drug interactions of Aredia and Temovate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Metastases to liver (cancer spreads to liver)
Metastases to lung (cancer spreads to lung)
Osteonecrosis of jaw (death of bone of jaw)
Breast cancer recurrent
Decreased interest
Emotional distress
Hepatic steatosis (fatty liver disease)
Hepatitis c
Mass
Splenomegaly (enlargement of spleen)

60+:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Abdominal pain
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Ascites (accumulation of fluid in the abdominal cavity)
Back pain
Blood glucose decreased
Bone pain
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiomegaly (increased size of heart than normal)

What are the existing conditions these people have? *

Resorption Bone Increased: 11 people, 78.57%
Metastases To Bone (cancer spreads to bone): 3 people, 21.43%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.14%
Bone Loss: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Aredia and Temovate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously